EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Salivary cell-free DNA in head and neck cancer: emerging clinical applications and future perspectives

Vaishnavi N Patel, Aditi B Patel, Shreya A Lotia, Vivek M Tanavde, Shanaya S Patel

Oncology Reviews · 10.07.2026 · 20

DOI: 10.3389/or.2026.1885622 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reviews, online erschienen am 10.07.2026. Verfasst von Vaishnavi N Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biological and Life Sciences, School of Arts and Sciences, Ahmedabad University, Ahmedabad, Gujarat, India. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck cancer (HNC) diagnosis and surveillance still rely primarily on clinical examination, imaging, and tissue biopsy, with no established non-invasive biomarkers for routine early detection or disease monitoring. This limitation underscores the need for alternative strategies that can facilitate timely diagnosis and longitudinal assessment. Salivary cell-free DNA (scfDNA) has emerged as a promising liquid biopsy biomarker owing to its close proximity to primary HNC lesions and its suitability for non-invasive, repeatable sampling. Detection and characterization of scfDNA enable the identification of tumour-associated molecular alterations, including somatic mutations, aberrant DNA methylation, copy number alterations, viral DNA, and fragmentation signatures, providing valuable insights into tumour biology and disease dynamics. These molecular features have demonstrated considerable potential for early detection, prognostication, therapeutic monitoring, and post-treatment surveillance in head and neck cancer. However, current data are derived largely from exploratory studies with heterogeneous methodologies, small validation cohorts, and limited standardization of analytical workflows. Nevertheless, advances in sample processing, extraction methods, high-sensitivity sequencing technologies, and advanced bioinformatic approaches are enhancing assay accuracy and reproducibility. This review summarizes the current evidence on scfDNA in HNC by delineating its biological basis, evaluating the robustness and translational relevance of available clinical studies, and examining the analytical, technical, and implementation challenges that must be addressed to facilitate its integration into evidence-based clinical practice.

Schlagwörter

Stichwörter der Autor:innen

diagnosishead and neck cancerliquid biopsyminimal residual diseaseprognosissalivary cell-free DNAtherapeutic monitoring

Autor:innen und Institutionen

  • Biological and Life Sciences, School of Arts and Sciences, Ahmedabad University, Ahmedabad, Gujarat, India.
  • Bioinformatics Institute, Agency for Science Technology and Research (A*STAR), Singapore, Singapore.

Förderung

  • Wellcome Trust

Zitieren

APA

Patel, V. N., Patel, A. B., Lotia, S. A., Tanavde, V. M., & Patel, S. S. (2026). Salivary cell-free DNA in head and neck cancer: emerging clinical applications and future perspectives. Oncology Reviews, 20. https://doi.org/10.3389/or.2026.1885622

Vancouver

Patel VN, Patel AB, Lotia SA, Tanavde VM, Patel SS. Salivary cell-free DNA in head and neck cancer: emerging clinical applications and future perspectives. Oncology Reviews. 2026;20. doi:10.3389/or.2026.1885622

BibTeX
@article{Patel2026,
  author = {Patel, Vaishnavi N and Patel, Aditi B and Lotia, Shreya A and Tanavde, Vivek M and Patel, Shanaya S},
  title = {Salivary cell-free DNA in head and neck cancer: emerging clinical applications and future perspectives},
  journal = {Oncology Reviews},
  year = {2026},
  volume = {20},
  doi = {10.3389/or.2026.1885622}
}
Kostenlos starten →